Bladder endometriosis – diagnostic and management challenges: A case report

In: Journal of Obstetrics and Gynaecology of Eastern and Central Africa · 2024 · vol. 36(1) · doi:10.59692/jogeca.v36i1.138 · W4391878888
article OA: diamond CC0

Abstract

Background: Urinary tract endometriosis (UTE) is the presence of endometriotic implants in the bladder,ureter, kidneys, or urethra. It affects ~1% of women with endometriosis and occurs more commonlyamong those with deep infiltrative endometriosis. Bladder endometriosis is the most commonpresentation, comprising 85% of cases. Concomitant involvement of the bladder and ureter is rare,comprising 1.4% of all cases. The clinical presentation involves lower urinary tract symptoms, thatworsen during menses. Timely diagnosis and treatment are crucial in ameliorating symptoms andpreventing complications, such as obstructive nephropathy. This is a case of bladder endometriosis withureteral involvement, outlining management challenges, reviewing evidence on managementapproaches, and highlighting the experience gained from this case in managing complex UTE.Case presentation: A 38-year-old female presented with a longstanding history of pelvic pain, dysuria,and new-onset voiding difficulty. She had undergone two prior surgical procedures for endometriosis,including a total abdominal hysterectomy. Her physical examination was normal. Ultrasound revealed a3-cm intracavitary bladder mass, which was described as likely endometriosis on magnetic resonanceimaging. On cystoscopy the mass was noted to be larger, encasing the left ureteric meatus. Alaparoscopic cystostomy was performed, with partial resection of the mass and placement of a temporaryureteric stent. After three months of medical treatment with dienogest, cystoscopy revealed a significantreduction in size with sub-centimeter residual avascular tissue. This was resected avoiding the ureter andureteric meatus. A new ureteric stent was placed. A repeat cystoscopy three months later revealed goodhealing with no residual endometriosis. The stent was removed, and a retrograde pyelogram confirmedno meatal stenosis or ureteric obstruction. She has remained symptom-free.Conclusion: Medical and surgical options are available for bladder endometriosis, with partialcystectomy being the gold standard. The initial approach is dependent on the size of the lesion and theextent of ureteric involvement. A staged approach that combines medical or surgical management canensure optimal outcomes while reducing surgery-associated morbidity in complex cases.
Full text 2,643 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Background

Urinary tract endometriosis (UTE) is the presence of endometriotic implants in the bladder, ureter, kidneys, or urethra. It affects ~1% of women with endometriosis and occurs more commonly among those with deep infiltrative endometriosis. Bladder endometriosis is the most common presentation, comprising 85% of cases. Concomitant involvement of the bladder and ureter is rare, comprising 1.4% of all cases. The clinical presentation involves lower urinary tract symptoms, that worsen during menses. Timely diagnosis and treatment are crucial in ameliorating symptoms and preventing complications, such as obstructive nephropathy. This is a case of bladder endometriosis with ureteral involvement, outlining management challenges, reviewing evidence on management approaches, and highlighting the experience gained from this case in managing complex UTE. Case presentation: A 38-year-old female presented with a longstanding history of pelvic pain, dysuria, and new-onset voiding difficulty. She had undergone two prior surgical procedures for endometriosis, including a total abdominal hysterectomy. Her physical examination was normal. Ultrasound revealed a 3-cm intracavitary bladder mass, which was described as likely endometriosis on magnetic resonance imaging. On cystoscopy the mass was noted to be larger, encasing the left ureteric meatus. A laparoscopic cystostomy was performed, with partial resection of the mass and placement of a temporary ureteric stent. After three months of medical treatment with dienogest, cystoscopy revealed a significant reduction in size with sub-centimeter residual avascular tissue. This was resected avoiding the ureter and ureteric meatus. A new ureteric stent was placed. A repeat cystoscopy three months later revealed good healing with no residual endometriosis. The stent was removed, and a retrograde pyelogram confirmed no meatal stenosis or ureteric obstruction. She has remained symptom-free.

Conclusion

Medical and surgical options are available for bladder endometriosis, with partial cystectomy being the gold standard. The initial approach is dependent on the size of the lesion and the extent of ureteric involvement. A staged approach that combines medical or surgical management can ensure optimal outcomes while reducing surgery-associated morbidity in complex cases. Downloads Published Issue Section Categories License Copyright (c) 2024 The Authors. This work is licensed under a Creative Commons Attribution 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisbladder_endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK